Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena

1. 14.

   SARS: Systematic Review of Treatment Effects · 2006

2. 35.

   Umbilical Cord as Prospective Source for Mesenchymal Stem Cell‐Based Therapy · 2016

3. 38.

   Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies · 2017

4. 45.

   Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV · 2020

5. 51.

   Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection · 2020

6. 53.

   The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus · 2020

7. 54.

   A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option · 2020

8. 55.

   MSC Based Therapies—New Perspectives for the Injured Lung · 2020

9. 61.

   SARS-CoV-2 and COVID-19: The most important research questions · 2020

10. 63.

    The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status · 2020

11. 66.

    Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia · 2020

12. 71.

    SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat · 2020

13. 77.

    Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 · 2020

14. 79.

    Effectiveness of convalescent plasma therapy in severe COVID-19 patients · 2020

15. 87.

    A Review of SARS-CoV-2 and the Ongoing Clinical Trials · 2020

16. 98.

    Effective treatment of severe COVID-19 patients with tocilizumab · 2020

17. 100.

    A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping · 2020

18. 110.

    CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells · 2020

100 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.